
Aphria
Medical Marijuana & Cannabis Oil Canada | Aphria.
Date | Investors | Amount | Round |
---|---|---|---|
N/A | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | $80.0m | Debt | |
Total Funding | 000k |


Related Content
Tilray Medical operates in the medical cannabis industry, offering a range of high-quality cannabis products designed to meet the needs of patients. The company serves a diverse clientele, including patients with chronic conditions, healthcare providers, and pharmacies. Tilray Medical operates primarily in the Canadian market but has a growing international presence. The business model revolves around the cultivation, production, and distribution of medical cannabis, generating revenue through direct sales to patients and wholesale agreements with healthcare institutions. The company emphasizes quality control and consistency, ensuring that all products meet stringent regulatory standards. Tilray Medical also invests in research and development to innovate and expand its product offerings.
Keywords: medical cannabis, patient care, quality control, chronic conditions, healthcare providers, pharmacies, Canadian market, international presence, cultivation, research and development.